MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202441039298 A) filed by University Of Hyderabad, Hyderabad, Telangana, on May 20, 2024, for 'novel heteroaromatic compounds.'
Inventor(s) include Anand K. Kondapi; C V Vidhya; Sarita Swain; and Kurumurthy Kammari.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to the 100M small molecules (UHAKKM-10, UHAKKM-11, and UHAKKM-12) that can inhibit the interaction between the SARS-CoV-2 virus and host cells. These small molecules target the Receptor Binding Domain (RBD) of the Spike protein, a crucial step in viral entry. The present invention also demonstrates methods for identifying and characterizing these antiviral small molecules, in particular, novel small molecules capable of inhibiting the interaction between the Receptor Binding Domain (RBD) of the SARS-CoV-2 virus and a host cell receptor, wherein the small molecule exhibits antiviral properties."
Disclaimer: Curated by HT Syndication.
